المؤلفون: Pacheco PAF; Laboratório de Toxoplasmose e outras Protozoosis, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. Electronic address: panastacio.fp@gmail.com., Diogo RT; Laboratório de Toxoplasmose e outras Protozoosis, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Programa de pós-graduação em Ciências e Biotecnologia, Instituto de Biologia - UFF, Niterói, Brazil., Magalhães BQ; Laboratório de Toxoplasmose e outras Protozoosis, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Programa de pós-graduação em Ciências e Biotecnologia, Instituto de Biologia - UFF, Niterói, Brazil., Faria RX; Laboratório de Toxoplasmose e outras Protozoosis, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Programa de pós-graduação em Ciências e Biotecnologia, Instituto de Biologia - UFF, Niterói, Brazil. Electronic address: robson.xavier@gmail.com.

المصدر: Fitoterapia [Fitoterapia] 2020 Oct; Vol. 146, pp. 104709. Date of Electronic Publication: 2020 Aug 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 16930290R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6971 (Electronic) Linking ISSN: 0367326X NLM ISO Abbreviation: Fitoterapia Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction*, Phytochemicals/*pharmacology , Receptors, Purinergic P2/*metabolism, Biological Products/pharmacology ; Clinical Trials as Topic ; Humans ; Ligands ; Purinergic P2 Receptor Agonists/pharmacology ; Purinergic P2 Receptor Antagonists/pharmacology

المؤلفون: Faria RX; Laboratory of Toxoplasmosis and Other Protozoans, Instituto Oswaldo Cruz, Avenida Brasil, 4365, Pavilion 108, room 32, CEP, Rio de Janeiro, Fiocruz, 21045-900, Brazil. salvador@ioc.fiocruz.br.; Postgraduate Program in Sciences and Biotechnology, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil. salvador@ioc.fiocruz.br., de Jesus Hiller N; Research Group on Catalysis and Synthesis, Laboratory 413, Instituto de Química, Universidade Federal Fluminense, Niterói, RJ, Brazil., Salles JP; Laboratory of Toxoplasmosis and Other Protozoans, Instituto Oswaldo Cruz, Avenida Brasil, 4365, Pavilion 108, room 32, CEP, Rio de Janeiro, Fiocruz, 21045-900, Brazil., Resende JALC; Laboratory of Solid State Chemistry, Instituto de Ciências Exatas e da Terra, Universidade Federal do Mato Grosso, Barra do Garças, MT, Brazil., Diogo RT; Laboratory of Toxoplasmosis and Other Protozoans, Instituto Oswaldo Cruz, Avenida Brasil, 4365, Pavilion 108, room 32, CEP, Rio de Janeiro, Fiocruz, 21045-900, Brazil.; Postgraduate Program in Sciences and Biotechnology, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil., von Ranke NL; Postgraduate Program in Sciences and Biotechnology, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil.; Departamento de Fármacos e Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Bello ML; Departamento de Fármacos e Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Rodrigues CR; Departamento de Fármacos e Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Castro HC; Postgraduate Program in Sciences and Biotechnology, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil., de Luna Martins D; Research Group on Catalysis and Synthesis, Laboratory 413, Instituto de Química, Universidade Federal Fluminense, Niterói, RJ, Brazil.

المصدر: Journal of bioenergetics and biomembranes [J Bioenerg Biomembr] 2019 Aug; Vol. 51 (4), pp. 277-290. Date of Electronic Publication: 2019 Jun 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 7701859 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-6881 (Electronic) Linking ISSN: 0145479X NLM ISO Abbreviation: J Bioenerg Biomembr Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Inflammatory Agents*/chemistry , Anti-Inflammatory Agents*/pharmacology , Boronic Acids*/chemistry , Boronic Acids*/pharmacology , Purinergic P2X Receptor Antagonists*/chemistry , Purinergic P2X Receptor Antagonists*/pharmacology, Receptors, Purinergic P2X7/*metabolism, Acetamides/chemistry ; Acetamides/pharmacology ; Animals ; HEK293 Cells ; Humans ; Inflammation/drug therapy ; Inflammation/genetics ; Inflammation/metabolism ; Inflammation/pathology ; Male ; Mice ; Quinolines/chemistry ; Quinolines/pharmacology ; Receptors, Purinergic P2X7/genetics